N-007

Naltrexone solution

Name: Naltrexone solution
Brand: CERILLIAN

1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

Slide 1 of 1

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

En este momento no podemos mostrarle ni los precios ni la disponibilidad

Acerca de este artículo

Fórmula empírica (notación de Hill):

C₂₀H₂₃NO₄

Número CAS:

16590-41-3

Peso molecular:

341.40

NACRES:

NA.24

PubChem Substance ID:

329818395

UNSPSC Code:

41116107

MDL number:

MFCD00242996

Documentos clave

Ver Toda la documentación

Saltar a

Servicio técnico

¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.

Permítanos ayudarle

Nombre del producto

Naltrexone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

InChI

1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1

SMILES string

Oc1ccc2C[C@H]3N(CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O)CC6CC6

InChI key

DQCKKXVULJGBQN-XFWGSAIBSA-N

grade

certified reference material

form

liquid

feature

Snap-N-Spike^®/Snap-N-Shoot^®

packaging

ampule of 1 mL

manufacturer/tradename

Cerilliant^®

concentration

1.0 mg/mL in methanol

technique(s)

gas chromatography (GC): suitable
liquid chromatography (LC): suitable

application(s)

forensics and toxicology

format

single component solution

shipped in

wet ice

storage temp.

2-8°C

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 4

Este artículo	N-004	N-038	N-047
Supelco N-007 Naltrexone solution	Supelco N-004 Naloxone solution	Supelco N-038 6β-Naltrexol solution	Supelco N-047 Naltrexone-D₃ solution
application(s) forensics and toxicology	application(s) forensics and toxicology	application(s) forensics and toxicology	application(s) pharmaceutical (small molecule)
technique(s) gas chromatography (GC): suitable, liquid chromatography (LC): suitable	technique(s) gas chromatography (GC): suitable, liquid chromatography (LC): suitable	technique(s) gas chromatography (GC): suitable, liquid chromatography (LC): suitable	technique(s) gas chromatography (GC): suitable, liquid chromatography (LC): suitable
form liquid	form liquid	form liquid	form liquid
format single component solution	format single component solution	format single component solution	format single component solution
Quality Level 300	Quality Level 300	Quality Level 300	Quality Level 300
grade certified reference material	grade certified reference material	grade certified reference material	grade certified reference material

General description

Naltrexone is an opiate sold under the trade names Revia, Depade and Vivitrol^® and is prescribed primarily for the management of alcohol or opiate dependence. This analytical reference standard is applicable for use in LC/MS or GC/MS applications such as pharmaceutical research, forensic analysis, clinical toxicology, pain prescription monitoring or urine drug testing.

Other Notes

Find a digital Reference Material for this product available on our online platform ChemisTwin® for NMR. You can use this digital equivalent on ChemisTwin® for your sample identity confirmation and compound quantification (with digital external standard). An NMR spectrum of this substance can be viewed and an online comparison against your sample can be performed with a few mouseclicks. Learn more here and start your free trial.

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Vivitrol is a registered trademark of Alkermes, Inc.

related product

Referencia del producto

Descripción

Precios

P-071

Pain Management Multi-component Opiate Mixture-13 solution, 100 μg/mL each component (10 μg/mL Fentanyl), ampule of 1.0 mL, certified reference material, Cerilliant^®

IMPN-007-02

10-Hydroxynaltrexone solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

IMPN-007-03

10-Ketonaltrexone solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

N-038

6β-Naltrexol solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

N-047

Naltrexone-D₃ solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

N-081

6β-Naltrexol-D₃ solution, 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

M-227

Methylnaltrexone bromide solution, 1 mg/mL in methanol, certified reference material, ampule of 1 mL, Cerilliant^®

M-228

Methylnaltrexone-D₃ bromide solution, 100 μg/mL in methanol ((as quarternary ammonium ion)), certified reference material, ampule of 1 mL, Cerilliant^®

pictograms

GHS02,GHS06,GHS08

signalword

Danger

hcodes

H225,H301 + H311 + H331,H370

pcodes

P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311

Hazard Classifications

Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1

target_organs

Eyes,Central nervous system

Clase de almacenamiento

3 - Flammable liquids

wgk

WGK 2

flash_point_f

49.5 °F - closed cup

flash_point_c

9.7 °C - closed cup

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Treatment of comorbid substance dependence and posttraumatic stress disorder.

Katherine Mills

JAMA, 310(5), 482-483 (2013-08-09)

[Pharmacogenetics and the treatment of addiction].

Arnt Schellekens

Nederlands tijdschrift voor geneeskunde, 157(23), A5725-A5725 (2013-06-07)

This article describes the current scientific knowledge regarding pharmacogenetic predictors of treatment outcome for substance-dependent patients. PubMed was searched for articles on pharmacogenetics and addiction. This search yielded 53 articles, of which 27 were selected. The most promising pharmacogenetic findings

Concurrent naltrexone and prolonged exposure therapy for patients with comorbid alcohol dependence and PTSD: a randomized clinical trial.

Edna B Foa et al.

JAMA, 310(5), 488-495 (2013-08-09)

Alcohol dependence comorbid with posttraumatic stress disorder (PTSD) has been found to be resistant to treatment. In addition, there is a concern that prolonged exposure therapy for PTSD may exacerbate alcohol use. To compare the efficacy of an evidence-based treatment

Monthly injectable naltrexone for pathological gambling.

Gihyun Yoon et al.

The American journal of psychiatry, 170(6), 682-683 (2013-06-05)

A FLIPR assay for evaluating agonists and antagonists of GPCR heterodimers.

Jessica H Harvey et al.

Methods in molecular biology (Clifton, N.J.), 995, 43-54 (2013-03-16)

Calcium signaling plays a major role in the function of cells. Measurement of intracellular calcium mobilization is a robust assay that can be performed in a high-throughput manner to study the effect of compounds on potential drug targets. Pharmaceutical companies

Ver todos los artículos relacionados

Artículos

Benefits of Ascentis Express Phenyl-Hexyl over Biphenyl for the Separation of Pain Management Opiates

Although both biphenyl and phenyl-hexyl phases can resolve these compounds, the former exhibits excellent peak shape and substantially less silanol-derived ion exchange activity.

Preguntas

Revisiones

Sin puntuación

Filtros activos

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico